Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

Cong Dai^{1

2}, Min Jiang¹, Ming-Jun Sun¹

Affiliations

Comment

Cong Dai et al. N Engl J Med. 2017.

. 2017 Aug 3;377(5):496.

doi: 10.1056/NEJMc1707500.

Cong Dai^{1

2}, Min Jiang¹, Ming-Jun Sun¹

No abstract available

Comment in

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Su C, Panes J. Sandborn WJ, et al. N Engl J Med. 2017 Aug 3;377(5):496-7. doi: 10.1056/NEJMc1707500. N Engl J Med. 2017. PMID: 28767341 No abstract available.

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Su C, Sands BE, D'Haens GR, Vermeire S, Schreiber S, Danese S, Feagan BG, Reinisch W, Niezychowski W, Friedman G, Lawendy N, Yu D, Woodworth D, Mukherjee A, Zhang H, Healey P, Panés J; OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators. Sandborn WJ, et al. N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910. N Engl J Med. 2017. PMID: 28467869 Clinical Trial.